BioCentury
ARTICLE | Company News

Advancell Advanced In Vitro Technologies S.A., BTG deal

November 16, 2009 8:00 AM UTC

BTG returned to Advancell its co-development rights for Acadra acadesine in exchange for an undisclosed potential milestone and royalties. BTG, which gained rights to the nucleoside analogue as part ...